Literature DB >> 23171092

Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.

Francesca Cerreta1, Hans-Georg Eichler, Guido Rasi.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23171092     DOI： 10.1056/NEJMp1209034

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

Review 1.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 2.  Managing multiple myeloma in elderly patients.

Authors:  Evan Diamond; Oscar B Lahoud; Heather Landau
Journal:  Leuk Lymphoma       Date:  2017-08-28

3.  Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.

Authors:  Antonio Palumbo; Sara Bringhen; Maria-Victoria Mateos; Alessandra Larocca; Thierry Facon; Shaji K Kumar; Massimo Offidani; Philip McCarthy; Andrea Evangelista; Sagar Lonial; Sonja Zweegman; Pellegrino Musto; Evangelos Terpos; Andrew Belch; Roman Hajek; Heinz Ludwig; A Keith Stewart; Philippe Moreau; Kenneth Anderson; Hermann Einsele; Brian G M Durie; Meletios A Dimopoulos; Ola Landgren; Jesus F San Miguel; Paul Richardson; Pieter Sonneveld; S Vincent Rajkumar
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

4.  Clusters of functional domains to identify older persons at risk of disability.

Authors:  Luisa Costanzo; Claudio Pedone; Matteo Cesari; Luigi Ferrucci; Stefania Bandinelli; Raffaele Antonelli Incalzi
Journal:  Geriatr Gerontol Int       Date:  2017-12-28       Impact factor: 2.730

5.  The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.

Authors:  Claire Johnston; Sarah N Hilmer; Andrew J McLachlan; Slade T Matthews; Peter R Carroll; Carl M Kirkpatrick
Journal:  Eur J Clin Pharmacol       Date:  2014-02-14       Impact factor: 2.953

Review 6.  Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population.

Authors:  Diana A van Riet-Nales; Katarina Sundberg; Anthonius de Boer; Blanka Hirschlérova
Journal:  Br J Clin Pharmacol       Date:  2020-10       Impact factor: 4.335

Review 7.  Oral anticoagulants in older adults with atrial fibrillation.

Authors:  Gwen M Bernacki; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

8.  Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.

Authors:  Cristiana Vitale; Giuseppe Rosano; Massimo Fini
Journal:  Wien Klin Wochenschr       Date:  2016-09-21       Impact factor: 1.704

Review 9.  Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models.

Authors:  S Stegemann; J-P Baeyens; R Becker; M Maio; M Bresciani; T Shreeves; F Ecker; M Gogol
Journal:  Z Gerontol Geriatr       Date:  2014-06       Impact factor: 1.281

10.  Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens.

Authors:  Kristian Heldal; Karsten Midtvedt
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.